Both in Pharmaceuticals
Xenetic Biosciences vs Azitra
Over the past year XBIO returned −29.5% and AZTR returned −82.7%; their daily moves had a correlation of 0.06.
XBIO −29.5% AZTR −82.7%Growth of $1, one year, split-adjusted
| Metric | XBIO | AZTR |
|---|---|---|
| Price | $2.01 | $0.8157 |
| Market cap | $4.7M | $4.9M |
| Today | −3.37% | −7.71% |
| 1 month | −5.2% | −37.3% |
| 6 months | −36.6% | −66.7% |
| Year to date | −7.4% | −69.2% |
| 1 year | −35.6% | — |
| Revenue growth (YoY) | +12.0% | — |
| Gross margin | 100.0% | — |
| Net margin | −140.7% | — |
| P/E (TTM) | — | — |
| Price / sales | 3.2× | — |
| Net cash | $6.5M | $6.7M |
| Dividend yield | — | — |
| Volatility (60d) | 158.5% | 222.1% |
| Short % of float | 0.5% | 0.2% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).